Foothill Ventures — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
NVIGENnvigen.comin𝕏Series B · Mar 2014 · $1M
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy.
BiotechHealthtechMedical DevicesSunnyvale, US
Aihua Fu(Executive Officer, Director, Promoter)inXiangdong Jin(Executive Officer)
BoardGuoliang Yu(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.